It doesn’t make sense for oral cancer treatments to be covered by a different part of patients’ health insurances from other cancer treatments, especially when this difference in coverage leads to big differences in cost for patients, as well. Treatment efficacy, not price, should be the deciding factor when patients are choosing between life-saving treatments.
“Oral parity” laws’ effectiveness seems to be mixed, based on available evidence. Additionally, policies like this don’t address the root cause of high healthcare costs in the U.S.: high drug prices. Rather than quibbling about how insurance covers extremely expensive drugs, it’d be a better use of Congress’s time to figure out how to make drugs more affordable, period.